PATIENTS with Hodgkin's disease (HD) frequently exhibit impaired cell-mediated immunity (Aisenberg, 1965) . Recent investigations indicate an anergy to recall antigens, failure of dinitrochlorobenzole sensitization, impaired mitogen reactivity (Case et al., 1976; Eltringham & Kaplan, 1973) and reduced proliferation in mixed lymphocyte cultures (Bjorkholm et al., 1976; Twomey et al., 1975) . In addition, lymphopenia (Young et al., 1972) and lower percentages of T lymphocytes (Colmen et al., 1973) have been reported. Data on monocyte function in HD are rare, though the Reed-Sternberg cell seems to be of macrophage origin (Kadin et al., 1978) . Reduced phagocytic activity of monocytes (Urbanitz et al., 1975) , decreased chemotactic response and monocyte bactericidal activity (Leb & Merritt, 1978) have been reported. We studied monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in patients with HD in order to investigate a further parameter of monocyte function. Increased ADCC of monocytes was detected in HD by using a particular in vitro ADCC system, in which antibody-coated human erythrocytes are killed by peripheralblood monocytes (Holm & Hammarstrom, 1973; Poplack et al., 1976; Pehamberger et at., 1980; Nyholm & Currie, 1978 (Leb & Merritt, 1978) (NSE) staining according to Koski et al. (1976 respectively) in patients than in the normals, at all 3 MNC :target cell ratios (Table) . No correlation was found between the lytic capacity of monocytes and the activity of the disease in the patients. The lytic capacity of the individual monocytes was calculated as the %51Cr release/103 monocytes, and was significantly higher in patients with HD than in controls (P < 0-02. Figure) . The proportion of monocytes of the MNC fraction was evaluated by NSE staining and was found not to be significantly different between (Gauci, 1975; Kjeldsberg & Pay, 1978) leading to the speculation that an attempt is made by the host to counter neoplastic invasion (Evans, 1976) . A strong mononuclear reaction has been found to be associated with a more favourable clinical prognosis (Kjeldsberg & Pay, 1978) . In patients with malignancies, especially those with rapidly progressive disease, several defects in the monocyte/macrophage system have been reported (Dizon & Southam, 1963; Evans, 1976; Currey & Hedley, 1977; Snyderman et al., 1977) . Moreover, monocyte abnormalities in cancer patients have been shown to be associated with poor prognosis (Normann et al., 1979) . Thus, the monocyte/macrophage system seems to play an important role in immune surveillance.
The cytolytic activity of monocytes against tumour cell is an important function of this cell type, besides its chemotactic, phagocytic, bactericidal and immuno-regulatory activity in the immune defence mechanism. In 1973, Holm & Hammarstrom described a test for the cytolytic activity of monocytes in which peripheral-blood monocytes lyse antibodycoated 51Cr-labelled human erythrocytes. The erythrolysis represents the lytic activity of the monocytes, and this assay is now regarded as a useful test for this particular monocyte function (Nyholm & Currie, 1978; Poplack et al., 1976; Pehamberger et al., 1980) . In previous experiments (Pehamberger et al., 1980 ) the monocyte nature of the effector cells in this particular test system had been further confirmed by enrichment (plastic dishes) and depletion (nylon wool) of adherent cells, X-irradiation, and pretreatment with carageenan and heataggregated IgG. In the present study this assay was applied in order to investigate monocyte-mediated ADCC in HD.
The percentage of monocyte-mediated 51Cr release was found to be significantly greater in patients with HD than in normals. Absolute numbers of monocytes, as determined by NSE staining, were not significantly different in both groups of individuals. In order to compare the lytic activity of the individual monocytes, the values of the 0 %5 1Cr release/ 103 monocytes of patients and controls were paired for statistical comparison. Thereby a possible bias due to the different individual monocyte :target cell ratios was eliminated. The 0%51Cr release/103 monocytes was significantly greater in patients with HD than in controls. With regard to the fact that no significant difference was found between the absolute numbers of monocytes in patients with HD and in normals, these results indicate that the lytic activity of the individual monocytes is increased in patients with HD. Interestingly, the cyto-780 I 0 toxicity of monocytes was independent of the activity of the disease. Two of the 3 patients with the highest 51Cr release/103 NSE+ cells (Figure) were in a clinically inactive state of the disease. In contrast, a correlation has been reported between enhanced monocyte suppressor cells and disease activity (Hillinger & Herzig, 1978) .
Previous investigations of monocyte function in HD have shown impairment of this particular cell type. Urbanitz et al. (1975) found reduced phagocytosis in patients with advanced HD and Leb & Merritt (1978) described decreased monocyte chemotactic response and monocyte bactericidal activity in that disorder. Recently, monocyte suppressor function was found to be significantly higher in HD, possibly impairing cellular immunity (Hillinger & Herzig, 1978) .
Our finding of increased cytolytic monocyte activity indicates that monocyte function is not generally impaired in HD but restricted to certain functions of this cell type. However, the question remains whether the increased cytolytic activity of monocytes in vitro actually represents the patients' response to an increasing number of tumour cells or, possibly, to an unknown infectious agent.
